130A Stock Chart & Stats
¥413.00
-¥4.00(-0.96%)
At close: 4:00 PM EDT
¥413.00
-¥4.00(-0.96%)
Day’s Range― - ―
52-Week Range¥390.00 - ¥793.00
Previous CloseN/A
Volume5.00K
Average Volume (3M)26.69K
Market Cap
¥2.79B
Enterprise Value¥1.37K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Nov 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-20.08
Shares Outstanding6,487,114
10 Day Avg. Volume17,220
30 Day Avg. Volume26,686
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Veritas In Silico Inc. News
130A FAQ
What was Veritas In Silico Inc.’s price range in the past 12 months?
Veritas In Silico Inc. lowest stock price was ¥390.00 and its highest was ¥793.00 in the past 12 months.
What is Veritas In Silico Inc.’s market cap?
Veritas In Silico Inc.’s market cap is ¥2.79B.
When is Veritas In Silico Inc.’s upcoming earnings report date?
Veritas In Silico Inc.’s upcoming earnings report date is Nov 13, 2026 which is in 67 days.
How were Veritas In Silico Inc.’s earnings last quarter?
Veritas In Silico Inc. released its earnings results on Aug 05, 2026. The company reported -¥20.08 earnings per share for the quarter.
Is Veritas In Silico Inc. overvalued?
According to Wall Street analysts Veritas In Silico Inc.’s price is currently Overvalued.
Does Veritas In Silico Inc. pay dividends?
Veritas In Silico Inc. does not currently pay dividends.
What is Veritas In Silico Inc.’s EPS estimate?
Veritas In Silico Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Veritas In Silico Inc. have?
Veritas In Silico Inc. has 6,487,114 shares outstanding.
What happened to Veritas In Silico Inc.’s price movement after its last earnings report?
Veritas In Silico Inc. reported an EPS of -¥20.08 in its last earnings report. Following the earnings report the stock price went down -3.133%.
Which hedge fund is a major shareholder of Veritas In Silico Inc.?
Currently, no hedge funds are holding shares in JP:130A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Veritas In Silico Inc.
Veritas In Silico Inc. engages in the development of molecular medicine drugs. It provides a platform business for the discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. The company was founded by Shingo Nakamura on November 17, 2016 and is headquartered in Tokyo, Japan.
Technical Analysis
Cosmo Bio Co., Ltd.
―
Ribomic, Inc.
―
Perseus Proteomics, Inc.
―
ReproCELL Inc.
―
Human Metabolome Technologies, Inc.
―